These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2047660)

  • 41. Drug resistance of Shigella strains isolated in Ankara, Turkey, 1993-1996.
    Aysev AD; Guriz H
    Scand J Infect Dis; 1998; 30(4):351-3. PubMed ID: 9817513
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative efficacy of ceftriaxone and ampicillin for treatment of severe shigellosis in children.
    Varsano I; Eidlitz-Marcus T; Nussinovitch M; Elian I
    J Pediatr; 1991 Apr; 118(4 Pt 1):627-32. PubMed ID: 2007941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial resistance of Shigella spp isolated from diarrheal patients between 1989 and 1998 in Vietnam.
    Anh NT; Cam PD; Dalsgaard A
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):856-62. PubMed ID: 12041563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative in vitro activity of tigecycline and other antimicrobial agents against Shigella species from Kuwait and the United Arab of Emirates.
    Jamal W; Rotimi VO; Pal T; Sonnevend A; Dimitrov TS
    J Infect Public Health; 2010; 3(1):35-42. PubMed ID: 20701889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.
    Rogerie F; Ott D; Vandepitte J; Verbist L; Lemmens P; Habiyaremye I
    Antimicrob Agents Chemother; 1986 May; 29(5):883-6. PubMed ID: 3524434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Shifting serotypes, plasmid profile analysis and antimicrobial resistance pattern of shigellae strains isolated from Kolkata, India during 1995-2000.
    Dutta S; Rajendran K; Roy S; Chatterjee A; Dutta P; Nair GB; Bhattacharya SK; Yoshida SI
    Epidemiol Infect; 2002 Oct; 129(2):235-43. PubMed ID: 12403099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiresistant Shigella infections in Bangladesh.
    Bennish M; Eusof A; Kay B; Wierzba T
    Lancet; 1985 Aug; 2(8452):441. PubMed ID: 2863461
    [No Abstract]   [Full Text] [Related]  

  • 48. Prevalence and antimicrobial susceptibility patterns of Shigella species in Asmara, Eritrea, northeast Africa.
    Naik DG
    J Microbiol Immunol Infect; 2006 Oct; 39(5):392-5. PubMed ID: 17066201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emergence of antibiotic resistant Shigella species: A matter of concern.
    Puzari M; Sharma M; Chetia P
    J Infect Public Health; 2018; 11(4):451-454. PubMed ID: 29066021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short-course norfloxacin and trimethoprim-sulfamethoxazole treatment of shigellosis and salmonellosis in Egypt.
    Bassily S; Hyams KC; el-Masry NA; Farid Z; Cross E; Bourgeois AL; Ayad E; Hibbs RG
    Am J Trop Med Hyg; 1994 Aug; 51(2):219-23. PubMed ID: 8074256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Childhood shigellosis in Saudi Arabia.
    Kagalwalla AF; Khan SN; Kagalwalla YA; Alola S; Yaish H
    Pediatr Infect Dis J; 1992 Mar; 11(3):215-9. PubMed ID: 1565538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Convulsions in childhood shigellosis and antimicrobial resistance patterns of shigella isolates.
    Oztürk MK; Caksen H; Sümerkan B
    Turk J Pediatr; 1996; 38(2):183-8. PubMed ID: 8701482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increasing antimicrobial resistance of Shigella isolates in Israel during the period 1984 to 1992.
    Ashkenazi S; May-Zahav M; Sulkes J; Zilberberg R; Samra Z
    Antimicrob Agents Chemother; 1995 Apr; 39(4):819-23. PubMed ID: 7785977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis.
    Salam MA; Bennish ML
    J Pediatr; 1988 Nov; 113(5):901-7. PubMed ID: 3054035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiology of shigellosis in Lagos, Nigeria: trends in antimicrobial resistance.
    Iwalokun BA; Gbenle GO; Smith SI; Ogunledun A; Akinsinde KA; Omonigbehin EA
    J Health Popul Nutr; 2001 Sep; 19(3):183-90. PubMed ID: 11761772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changing patterns of serotypes and antimicrobial susceptibilities of Shigella species isolated from children in Calcutta, India.
    Niyogi SK; Mitra U; Dutta P
    Jpn J Infect Dis; 2001 Jun; 54(3):121-2. PubMed ID: 11544405
    [No Abstract]   [Full Text] [Related]  

  • 57. Decreased susceptibility to antimicrobials among Shigella flexneri isolates in Manipal, South India--a 5 year hospital based study.
    Mamatha B; Rituparna C
    Southeast Asian J Trop Med Public Health; 2012 Nov; 43(6):1447-51. PubMed ID: 23413708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Death from multi-resistant shigellosis in Fiji Islands.
    Watson C
    Pac Health Dialog; 2001 Mar; 8(1):99-102. PubMed ID: 12017845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Shigellosis of childhood in northern Greece: epidemiological, clinical and laboratory data of hospitalized patients during the period 1971-96.
    Kavaliotis J; Karyda S; Konstantoula T; Kansouzidou A; Tsagaropoulou H
    Scand J Infect Dis; 2000; 32(2):207-11. PubMed ID: 10826910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimicrobial susceptibility patterns of Shigella isolates in Foodborne Diseases Active Surveillance Network (FoodNet) sites, 2000-2010.
    Shiferaw B; Solghan S; Palmer A; Joyce K; Barzilay EJ; Krueger A; Cieslak P
    Clin Infect Dis; 2012 Jun; 54 Suppl 5():S458-63. PubMed ID: 22572670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.